Cargando…

Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis

OBJECTIVES: Retroperitoneal fibrosis (RPF) is a rare autoimmune disease with fibrous tissue growth and inflammation in retroperitoneum. Its current treatments involve long-term uptake of glucocorticoids (e.g., prednisone) for controlling inflammation; however, side effects are common. We strived for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Hui, Liu, Shibo, Mai, Yuanbang, Wang, Yuying, Zhang, Xuewu, Zheng, Shufen, Luo, Chenghua, Pan, Cuiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Autoinflammatory Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176363/ https://www.ncbi.nlm.nih.gov/pubmed/36720581 http://dx.doi.org/10.1136/ard-2022-223736

Ejemplares similares

Correction: Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
Publicado: (2023)

Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease
por: Shigemura, Tomonari, et al.
Publicado: (2016)

Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study
por: Helmers, Sevim Barbasso, et al.
Publicado: (2016)

Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases
por: Savic, Sinisa, et al.
Publicado: (2017)

Polymyalgia rheumatica: an autoinflammatory disorder?
por: Floris, Alberto, et al.
Publicado: (2018)

Haploinsufficiency of A20 impairs protein–protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation
por: Rajamäki, Kristiina, et al.
Publicado: (2018)

Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever
por: Van Gorp, Hanne, et al.
Publicado: (2020)

Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
por: Ozen, Seza, et al.
Publicado: (2020)

Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
por: Kacar, Mark, et al.
Publicado: (2020)

Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome
por: Kuemmerle-Deschner, Jasmin Beate, et al.
Publicado: (2020)

Contrasting role of NLRP12 in autoinflammation: evidence from a case report and mouse models
por: Lévy, Dan, et al.
Publicado: (2021)

COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases
por: Bourguiba, Rim, et al.
Publicado: (2022)

Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry
por: Walker, Ulrich A, et al.
Publicado: (2021)

Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers
por: Rasch, Mads Nyhuus Bendix, et al.
Publicado: (2022)

Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome
por: Kozycki, Christina Torres, et al.
Publicado: (2022)

Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients
por: Khitri, Mohamed-Yacine, et al.
Publicado: (2022)

Distinct immune-effector and metabolic profile of CD8(+) T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitors
por: Benesova, Karolina, et al.
Publicado: (2022)

Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study
por: Sun, Ruijie, et al.
Publicado: (2023)

SAPHO syndrome can cause sausage finger lesions
por: Jiang, Haixu, et al.
Publicado: (2023)

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
por: Mascaro, Jose Manuel, et al.
Publicado: (2023)

Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Characteristics and outcome of critically ill patients with systemic rheumatic diseases referred to the intensive care unit
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2023)

Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
por: Ruscitti, Piero, et al.
Publicado: (2023)

Clinical Presentation and Pathogenesis of Cold-Induced Autoinflammatory Disease in a Family With Recurrence of an NLRP12 Mutation
por: Borghini, S, et al.
Publicado: (2011)

Long-Term Clinical Profile of Children With the Low-Penetrance R92Q Mutation of the TNFRSF1A Gene
por: Pelagatti, M A, et al.
Publicado: (2011)

Association of the Leukocyte Immunoglobulin‐like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult‐Onset Still’s Disease
por: Wang, Mengyan, et al.
Publicado: (2021)

Novel Majeed Syndrome–Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis
por: Bhuyan, Farzana, et al.
Publicado: (2021)

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation
por: Yan, Kai, et al.
Publicado: (2022)

Mycophenolate mofetil/prednisone/sirolimus: Various toxicities: case report
Publicado: (2020)

Low-dose sirolimus in retroperitoneal lymphangioleiomyomas
por: Ussavarungsi, Kamonpun, et al.
Publicado: (2019)

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801
por: Carpenter, Paul A., et al.
Publicado: (2018)

Rapid Shrinkage of Retroperitoneal Lymphangioleiomyoma after Sirolimus Initiation
por: Hirose, Minori, et al.
Publicado: (2021)

The Effectiveness of Sirolimus Treatment in Two Rare Disorders with Nonketotic Hypoinsulinemic Hypoglycemia: The Role of mTOR Pathway
por: Şıklar, Zeynep, et al.
Publicado: (2020)

Early Adjuvant Medication With the mTOR Inhibitor Sirolimus in a Preterm Neonate With Compressive Cystic Lymphatic Malformation
por: Honnorat, Marion, et al.
Publicado: (2020)

Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy
por: Park, Haeseong, et al.
Publicado: (2016)

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours
por: Martin-Liberal, J, et al.
Publicado: (2014)

Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression
por: Bak, Szilvia, et al.
Publicado: (2018)

mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis
por: Gui, Yao-Song, et al.
Publicado: (2015)

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
por: Lawrence, Jessica, et al.
Publicado: (2018)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ua5q3vrtlriiofhnd2e9qic9kv